I would simply note that efforts are being made on a broad number of fronts in Canada, from working with firms and research labs that have potential vaccine candidates, to providing support to researchers not only to do the research but to ensure that we can participate in clinical trials, and then to ensure that we have a rapid process to approve clinical trial designs as well for the different phases of candidate vaccines as they emerge, to ensure their safety and effectiveness. All of these efforts are being co-ordinated through work between federal agencies, as noted.
That timeline of 12 to 18 months for a vaccine is what is being discussed globally, but there is no certainty on that, which is why every effort is being made not only on vaccine development in Canada and Canadian participation as candidate vaccines emerge globally, but also on the development of treatments or therapies that can help manage the symptoms. The solidarity trial that was noted is important in that regard as well, as is work by Canadian firms and researchers across the country.